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Background: Optimal management of acute right heart failure following the implantation of a left ventricular assist
device requires a reliable estimation of left ventricular preload and contractility. This is possible by real-time pump
blood flow measurements.
Clinical case: We performed implantation of a continuous flow left ventricular assist device in a 66 years old female
patient with an end-stage heart failure on the grounds of a dilated cardiomyopathy. Real-time pump blood flow
was directly measured by an ultrasonic flow probe placed around the outflow graft.
Diagnosis: The progressive decline of real time flow and the loss of pulsatility were associated with an increase of
central venous pressure, inotropic therapy and progressive renal failure suggesting the presence of an acute right
heart failure. Diagnosis was validated by echocardiography and thermodilution measurements.
Treatment: Temporary mechanical circulatory support of the right ventricle was successfully performed. Real time
flow measurement proved to be a useful tool for the diagnosis and ultimately for the management of right heart
failure including the weaning from extracorporeal membrane oxygenation.
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Right heart failure is a common complication following
left ventricular circulatory support [1]. Diagnosis and
management are usually based upon echocardiographic
findings and measurements of mixed venous saturation
which provide information about left ventricular preload
and left ventricular contractility. Alternatively this infor-
mation could be easily obtained by the pump blood flow
estimated by the left ventricular assist device. However
this would not be accurate since currently available
assist devices do not measure real-time blood flow but
only calculate it using the rotational speed of the pump
and the power consumption of the motor. Furthermore
this calculation would be susceptible to external factors* Correspondence: sotirios.spiliopolos@ejk.de
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distribution, and reproduction in any mediumsuch as blood viscosity [2]. In contrast, real-time blood
flow measurements are accurate. In this paper we
describe a case of an acute right heart failure following
left ventricular circulatory support which was diagnosed
and successfully managed based upon information
obtained through real-time blood flow measurements.Case presentation
A continuous flow left ventricular assist device (HeartAssist
5; Micromed Cardiovascular Inc. Houston, USA) was
implanted in a 66 years old female patient with an end-
stage heart failure NYHA IV with a history of dilated car-
diomyopathy. Preoperative echocardiography showed a
severe impairment of the left ventricular function (EF 10%),
a secondary pulmonary hypertension with an estimated sys-
tolic pulmonary artery pressure of 48 mmHg and a right
ventricular dysfunction with a tricuspid annular plane
systolic excursion (TAPSE) of 15 mm. The cardiac output,ntral Ltd. This is an Open Access article distributed under the terms of the
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(Cardiac Index 1,92 L/min/m2) with a systemic peripheral
vascular resistance of 1350 dyn.sec.cm5 and pulmonary
vascular resistance of 383 dyn·s/cm5). After four days intra-
venous therapy with milrinone (14 μg/kg/hr)., cardiac out-
put improved to 4,6 L/min (Cardiac Index 2,5 L/min/m2)
with a systemic vascular resistance of 1000 dyn·s/cm5 and
pulmonary vascular resistance decreased to 190 dyn·s/ cm5.
After implant of the HeartAssist5, the thorax could not be
completely closed, due to severe fluid retention and
oedema. Complete closure resulted in severe right ven-
tricular failure. During the first and the second post-
operative day the mean real-time flow was 4,8 L/min
(range: 4,4 L/min-5,2 L/min) at a fixed pump speed of
8400 rpm (range: 8300–8500 rpm) and the flow wave-
forms showed very pulsatile flows (2.0 L/min in diastole
and 6.5 L/min in systole). In the third postoperative day
the mean real-time flow decreased to 4,3 L/min (range:
3,9-5,1 L/min) and the flow curve became flat. Real time
flow was correlated to cardiac output measured by ther-
modilution (4,07 L/min on a systemic peripheral vascu-
lar resistance of 766 dyn·s/cm5). Initialy a low-dose
inotropic therapy with milrinone (3 μg/kg/hr), noradre-
nalin (1 μg/kg/hr) and dopamine (200 μg/kg/hr) was
enough to restore cardiac output (4,7 L/min with a sys-
temic vascular resistance of 938 dyn·s/cm5). Unfortu-
nately, in the eighth postoperative day, the central venous
pressure increased from 9 mmHg to a mean 16 mmHg
(range 14–20 mmHg) and the real-time flow decreased
(mean 3,9 L/min, range 3,5-4,7 L/min). 24 hours later the
patient developed renal failure, necessitating haemodialy-
sis and a high dose inotropic therapy became mandatory
(norepinephrine 8 μg/kg/hr, Milrinone 11 μg/kg/hr). Des-
pite maximal inotropic therapy, flows continued to decline
and on the tenth postoperative day the patient was placed
on venoarterial extracorporeal membrane oxygenation
(Levitronix Centrimag, Zurich, Switzerland). The two-stage
venous cannula was inserted to the right atrium and the ar-
terial cannula in the main pulmonary artery. Real time flow
& pulsatility recovered promptly. Mean flow values over
the first 24 hours ranged from 4,8 L/min to 6,2 L/min at a
fixed pump speed of 8700 rpm. After four days of ECMO,
the inotropes were weaned. At the sixth day of ECMO sup-
port, weaning from ECMO was started. Mean real time
flow remained stable over the weaning procedure (5 L/min;
range 4,3-5,5 L/min). The ECMO circuit was disconnected
at the 14th post-operative day. Three days after ECMO re-
moval, the Thorax was closed, and the further course was
uneventful.
Conclusions
Currently available continuous flow ventricular assist
devices estimate the pump blood flow with a calculation
using the power consumption of the motor and therotational speed of the pump [3]. However, it is known
that the estimated blood flow depends to a large extent
from external factors such as blood viscosity [2], rotational
speed and loading of the ventricle. The estimated blood
flow is therefore not accurate. Right heart failure is a com-
mon complication following left ventricular circulatory
support [1]. The main reasons are a shift of the interven-
tricular septum to the left and the inability of a dysfunc-
tional right ventricle to cope with the increased venous
return, delivered by the LVAD. It is therefore essential for
the management of right ventricular failure to precisely
determine the left ventricular preload and contractility.
This is quite well possible by the means of transesophageal
echocardiography and mixed venous saturation but is only
available in the early post-op phase. The HeartAssist 5 left
ventricular assist device instead has an ultrasonic flow
probe placed around the outflow graft which provides
real-time flow measurement [4]. This measurement is reli-
able and gives information about the left ventricular pre-
load and the left ventricular contractility [5]. In our case
real time flow was repeatedly validated by haemodynamic
measurements obtained by thermodilution. The progres-
sive decline of real time flow and loss of pulsatility was
associated with an increase of central venous pressure,
inotropic therapy and progressive renal failure requiring
ultimately a mechanical circulatory support of the right
ventricle. Furthermore the real time flow measurement
proved to be a useful tool for the weaning from the extra-
corporeal membrane oxygenation since it enabled the
monitoring of the left ventricular preload & contractility
(0.6 – 8.3 L/min) throughout the post-operative course.
The loss of pulsatility in the flow curve is an early warning
sign for insufficient preload of the LV, which will allow
earlier intervention and therefore may help to better man-
age critically ill patients. Furthermore real-time flow mea-
surements proved to be a useful tool and a reliable
alternative to conventional techniques for the measure-
ment of cardiac output in the clinical setting.
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